The Public Health Commission has just approved vaccination in minors between 5 and 11 years of age. After the OK from the European Medicines Agency (EMA) and the approval of the Vaccine Presentation, this was the last step towards starting the vaccination campaign in the last segment of the population that remained unvaccinated (and that, for that very reason, accumulates an incidence twice as large as the general average and three times more than adolescents).
A controversial vaccination campaign, but taken for granted
If all goes according to plan, the first vials of the Pfizer preparation will arrive in the country on December 13 and will be ready so that on the 15th the communities can get down to work. It is expected that until the end of January, more than three million of these vaccines will be given (although the process will take a little longer due to the double vaccination schedule).
The childhood vaccine has been a very controversial topic because, as is well known, the disease is less virulent in minors and that makes the decision to vaccinate or not is not identical to the case of adults. However, finally, it has been the high incidence that has motivated the decision to inoculate minors. According to EMA data, the vaccine would limit the possibility of children becoming vectors of the pandemic and keeping the virus circulating.
Post in update